01 1Productos Quimicos Naturales S.A. de C.V.
02 1Sterling S.p.A.
01 1ESTROPIPATE
02 1estropipate
01 1Italy
02 1Mexico
NDC Package Code : 12875-9998
Start Marketing Date : 2010-11-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64918-0106
Start Marketing Date : 2015-10-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Estropipate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Estropipate, including repackagers and relabelers. The FDA regulates Estropipate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Estropipate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Estropipate supplier is an individual or a company that provides Estropipate active pharmaceutical ingredient (API) or Estropipate finished formulations upon request. The Estropipate suppliers may include Estropipate API manufacturers, exporters, distributors and traders.
click here to find a list of Estropipate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Estropipate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Estropipate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Estropipate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Estropipate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Estropipate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Estropipate suppliers with NDC on PharmaCompass.
We have 2 companies offering Estropipate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
